Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sabrina Bryant"'
Autor:
Sabrina Bryant, Iyad Almahmoud, Isabelle Pierre, Julie Bardet, Saber Touati, Daniele Maubon, Muriel Cornet, Claire Richarme, Max Maurin, Patricia Pavese, Yvan Caspar
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Molecular rapid diagnostic assays associated with antimicrobial stewardship have proven effective for the early adaptation of empiric therapy in bloodstream infections. The ePlex® BCID (GenMark Diagnostics) Panels allow identification of 56 bacteria
Externí odkaz:
https://doaj.org/article/93861fd280b94a6c931fd4782ccf459d
Autor:
Isabelle Pierre, Sabrina Bryant, Iyad Almahmoud, Muriel Cornet, Yvan Caspar, Claire Richarme, Saber Touati, Danièle Maubon, Julie Bardet, Max Maurin, Patricia Pavese
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 10 (2020)
Molecular rapid diagnostic assays associated with antimicrobial stewardship have proven effective for the early adaptation of empiric therapy in bloodstream infections. The ePlex® BCID (GenMark Diagnostics) Panels allow identification of 56 bacteria
Publikováno v:
Laboratory Medicine. 38:153-155
1. What are this patient’s most striking clinical and laboratory findings? 2. How do you explain this patient’s most striking clinical and laboratory findings? 3. What is this patient’s most likely diagnosis? 4. What is the most common parasite
Autor:
Sabrina Bryant
Publikováno v:
Clinical laboratory science : journal of the American Society for Medical Technology. 26(3)
From 2006 through 2008, patient safety events cost the Medicare program $8.9 billion and were associated with 99,180 hospital deaths.1 Of the $2.5 trillion spent on healthcare in 2009, 2.3% or $57.5 million was spent on laboratory costs.2 Reduction o
Autor:
Shawn R, Clinton, Kevin L, Beason, Sabrina, Bryant, James T, Johnson, Margaret, Jackson, Cynthia, Wilson, Kay, Holifield, Charlton, Vincent, Margot, Hall
Publikováno v:
Biomedical sciences instrumentation. 39
Breast cancer is currently the third most common cause of cancer in the world. Circulating tumor antigens are often used as a minimally invasive tool for noting breast cancer progression. The objective of this study was to compare four tumor antigens
Publikováno v:
Laboratory Medicine; Mar2007, Vol. 38 Issue 3, p153-155, 3p